4//SEC Filing
Wilson Mark Andrew 4
Accession 0000950170-24-129462
CIK 0000906709other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 8:36 PM ET
Size
5.6 KB
Accession
0000950170-24-129462
Insider Transaction Report
Form 4
Wilson Mark Andrew
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-11-19$1.01/sh−6,407$6,471→ 218,856 total
Footnotes (3)
- [F1]Represents the number of shares sold by the reporting person to cover required tax withholding obligations in connection with the vesting of the RSUs held by the reporting person and does not represent a discretionary trade by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.00 to $1.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon the request to the SEC staff, the Issuer, or a security holder of the Issuer.
- [F3]This number includes 6,607 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001808356
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 8:36 PM ET
- Size
- 5.6 KB